These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
404 related items for PubMed ID: 7543127
1. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy. Kovacs CS, MacDonald SM, Chik CL, Bruera E. J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127 [Abstract] [Full Text] [Related]
2. Pathophysiology and management of severe hypercalcemia. Nussbaum SR. Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291 [Abstract] [Full Text] [Related]
4. [Palliative therapy in cancer. 4. Palliation of the symptoms from a malignant tumor. (2)]. Urushizaki I. Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1525-35. PubMed ID: 1697156 [Abstract] [Full Text] [Related]
5. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia. Audran M, Minebois-Villégas A, Lortholary A, Legrand E, Pascaretti C, Giraud P, Subra JF, Boasson M, Jallet P. Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336 [Abstract] [Full Text] [Related]
6. Cancer-induced hypercalcemia. Lumachi F, Brunello A, Roma A, Basso U. Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365 [Abstract] [Full Text] [Related]
7. Hypercalcemia: an evidence-based approach to clinical cases. Assadi F. Iran J Kidney Dis; 2009 Apr; 3(2):71-9. PubMed ID: 19395781 [Abstract] [Full Text] [Related]
8. A practical approach to hypercalcemia. Carroll MF, Schade DS. Am Fam Physician; 2003 May 01; 67(9):1959-66. PubMed ID: 12751658 [Abstract] [Full Text] [Related]
9. [Medical treatment of malignant hypercalcemia]. Eto S, Nakano Y, Okada Y. Gan To Kagaku Ryoho; 1993 Dec 01; 20(15):2311-8. PubMed ID: 8259844 [Abstract] [Full Text] [Related]
10. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia. Rosner MH, Dalkin AC. Clin J Am Soc Nephrol; 2012 Oct 01; 7(10):1722-9. PubMed ID: 22879438 [Abstract] [Full Text] [Related]
12. [Hypercalcemia in malignancy]. Eto S. Rinsho Byori; 1994 Sep 01; 42(9):943-51. PubMed ID: 7967119 [Abstract] [Full Text] [Related]
13. Hypercalcemia of malignancy: pathophysiology and implications for treatment. Theriault RL. Oncology (Williston Park); 1993 Jan 01; 7(1):47-50; discussion 52-5. PubMed ID: 8420542 [Abstract] [Full Text] [Related]
14. Mechanisms and treatment of hypercalcemia of malignancy. Clines GA. Curr Opin Endocrinol Diabetes Obes; 2011 Dec 01; 18(6):339-46. PubMed ID: 21897221 [Abstract] [Full Text] [Related]
15. Current management strategies for hypercalcemia. Pecherstorfer M, Brenner K, Zojer N. Treat Endocrinol; 2003 Dec 01; 2(4):273-92. PubMed ID: 15966562 [Abstract] [Full Text] [Related]
16. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors. Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E. Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357 [Abstract] [Full Text] [Related]
17. Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy. Reagan P, Pani A, Rosner MH. Am J Kidney Dis; 2014 Jan 01; 63(1):141-7. PubMed ID: 24021907 [Abstract] [Full Text] [Related]
18. [Treatment of malignancy-associated hypercalcemia]. Endo I, Inoue D. Clin Calcium; 2006 Apr 01; 16(4):665-69. PubMed ID: 16582519 [Abstract] [Full Text] [Related]
19. Hypercalcemia of malignancy: a review of advances in pathophysiology. Kaplan M. Oncol Nurs Forum; 1994 Jul 01; 21(6):1039-46; quiz 1047-8. PubMed ID: 7971410 [Abstract] [Full Text] [Related]
20. Etiology and current management of cancer-related hypercalcemia. Warrell RP. Oncology (Williston Park); 1992 Oct 01; 6(10):37-43; discussion 43, 47-50. PubMed ID: 1390013 [Abstract] [Full Text] [Related] Page: [Next] [New Search]